Reliability and usefulness of spirometry performed during admission for COPD exacerbation

PLoS ONE

Volumn 13, Issue 3, 2018, Pages

  Fernández Villar, Alberto ^a,b   Represas Represas, Cristina ^a,b   Mouronte Roibás, Cecilia ^a,b   Ramos Hernández, Cristina ^a,b   Priegue Carrera, Ana ^a,b   Fernández García, Sara ^a,b   López Campos, José Luis ^c,d  

^a Alvaro Cunqueiro Hospital   (Spain)

^b Research Group on Rare Diseases and Pediatric Medicine   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

EID: 85044508734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194983     Document Type: Article

References (28)

1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol. 2017; 53:128-49. https://doi.org/10.1016/j.arbres.2017.02. 001 PMID: 28274597
2. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol. 2017; 53:324-35. https://doi.org/10.1016/j.arbres.2017.03. 018 PMID: 28477954
3. Lopez-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med. 2014; 2:54-62. https://doi.org/10.1016/S2213-2600(13)70232-7 PMID: 24461902
4. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015; 148:971-85. https://doi.org/10.1378/chest.14-2535 PMID: 25950276
5. Fernandez-Villar A, Soriano JB, Lopez-Campos JL. Overdiagnosis of COPD: precise definitions and proposals for improvement. Br J Gen Pract. 2017; 67:183-4. https://doi.org/10.3399/bjgp17X690389 PMID: 28360069
6. Lopez-Campos JL, Soriano JB, Calle M, Encuesta de Espirometria en Espana. A comprehensive, national survey of spirometry in Spain: current bottlenecks and future directions in primary and secondary care. Chest. 2013; 144:601-9. https://doi.org/10.1378/chest.12-2690 PMID: 23411500
7. Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S, European COPD Audit team. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax. 2013; 68:1169-71. https://doi.org/10.1136/thoraxjnl-2013-203465 PMID: 23729193
8. Fernandez-Villar A, Lopez-Campos JL, Represas Represas C, Marin Barrera L, Leiro Fernandez V, Lopez Ramirez C, et al. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis. Int J Chron Obstruct Pulmon Dis. 2015; 10:961-7. https://doi.org/10.2147/COPD.S79547 PMID: 26028969
9. Wu H, Wise RA, Medinger AE. Do Patients Hospitalized With COPD Have Airflow Obstruction? Chest. 2017; 151:1263-71 https://doi.org/10.1016/j.chest.2017.01.003 PMID: 28089815
10. Spero K, Bayasi G, Beaudry L, Barber KR, Khorfan F. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017; 12:2417-23. https://doi.org/10.2147/COPD.S139919 PMID: 28860736
11. Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013; 8:389-95. https://doi.org/10.2147/COPD.S48659 PMID: 24009418
12. Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016; 47:113-21. https://doi.org/10.1183/13993003.01391-2014 PMID: 26493806
13. Rinne ST, Hebert PL, Wong ES, Au DH, Bastian LA, Nembhard IM, et al. Organizational Practices Affecting Chronic Obstructive Pulmonary Disease Readmissions. Am J Respir Crit Care Med. 2017; 195:1269-72. https://doi.org/10.1164/rccm.201609-1783LE PMID: 28459333
14. Rea H, Kenealy T, Adair J, Robinson E, Sheridan N. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2011; 6:527-32. https://doi.org/10.2147/COPD.S24133 PMID: 22069364
15. Prieto Centurion V, Huang F, Naureckas ET, Camargo CA Jr., Charbeneau J, Joo MJ, et al. Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012; 12:73. https://doi.org/10.1186/1471-2466-12-73 PMID: 23217023
16. Shah T, Press VG, Huisingh-Scheetz M, White SR. COPD Readmissions: Addressing COPD in the Era of Value-based Health Care. Chest. 2016; 150:916-26. https://doi.org/10.1016/j.chest.2016.05.002 PMID: 27167208
17. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005; 26:420-8. https://doi.org/10.1183/09031936.05.00136304 PMID: 16135722
18. Cushen B, McCormack N, Hennigan K, Sulaiman I, Costello RW, Deering B. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program. Respir Med. 2016; 119:55-62. https://doi.org/10.1016/j.rmed.2016.08.019 PMID: 27692148
19. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54:581-6. PMID: 10377201
20. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34:648-54. https://doi.org/10.1183/09031936. 00102509 PMID: 19720809
21. Garcia-Rio F, Pino JM, Dorgham A, Alonso A, Villamor J. Spirometric reference equations for European females and males aged 65-85 yrs. Eur Respir J. 2004; 24:397-405. https://doi.org/10.1183/09031936.04.00088403 PMID: 15358698
22. Garcia-Rio F, Calle M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al. Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2013; 49:388-401. PMID: 23726118
23. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948-68. https://doi.org/10.1183/09031936.05.00035205 PMID: 16264058
24. Guerra B, Gaveikaite V, Bianchi C, Puhan MA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017; 26.
25. Perez-Padilla R, Wehrmeister FC, Montes de Oca M, Lopez MV, Jardim JR, Muino A, et al. Instability in the COPD diagnosis upon repeat testing vary with the definition of COPD. PLoS One. 2015; 10: e0121832. https://doi.org/10.1371/journal.pone.0121832 PMID: 25811461
26. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014; 44:873-84. https://doi.org/10.1183/09031936.00025214 PMID: 24993906
27. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014; 2:195-203. https://doi.org/10.1016/S2213-2600(14)70001-3 PMID: 24621681
28. Miravitlles M, Garcia-Sidro P, Fernandez-Nistal A, Buendia MJ, Espinosa de los Monteros MJ, Molina J. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013; 11:147. https://doi.org/10.1186/1477-7525-11-147 PMID: 23987232